Last 12 months
Inside the activity.
0 purchase rows · 19 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 04, 2022 Filed May 6, 2022 20:06 UTC |
Andres JuanSee remarks
|
Exercise / conversionCommon Stock | 2,000 | $14.22 | $28,440.00 |
DisclosureSEC source: 0001127602-22-013640 · form4.xml · nonDerivative · entry 1 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,069 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2021. Read SEC document |
| May 03, 2022 Filed May 4, 2022 20:37 UTC |
Hoge StephenPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001127602-22-013200 · form4.xml · derivative · entry 8 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,431 Underlying: Common Stock · 10,000 shares Expires 2023-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| May 03, 2022 Filed May 4, 2022 20:37 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 10,000 | $141.93 | $1,419,300.00 |
DisclosureSEC source: 0001127602-22-013200 · form4.xml · nonDerivative · entry 4 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,622,532 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021. Read SEC document |
| May 03, 2022 Filed May 4, 2022 20:37 UTC |
Hoge StephenPresident
|
Exercise / conversionCommon Stock | 10,000 | $0.99 | $9,900.00 |
DisclosureSEC source: 0001127602-22-013200 · form4.xml · nonDerivative · entry 3 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,632,532 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021. Read SEC document |
| May 02, 2022 Filed May 4, 2022 20:37 UTC |
Hoge StephenPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001127602-22-013200 · form4.xml · derivative · entry 7 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,431 Underlying: Common Stock · 10,000 shares Expires 2023-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| May 02, 2022 Filed May 4, 2022 20:37 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 10,000 | $134.87 | $1,348,700.00 |
DisclosureSEC source: 0001127602-22-013200 · form4.xml · nonDerivative · entry 2 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,622,532 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021. Read SEC document |
| May 02, 2022 Filed May 4, 2022 20:37 UTC |
Hoge StephenPresident
|
Exercise / conversionCommon Stock | 10,000 | $0.99 | $9,900.00 |
DisclosureSEC source: 0001127602-22-013200 · form4.xml · nonDerivative · entry 1 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,632,532 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021. Read SEC document |
| April 29, 2022 Filed May 2, 2022 20:24 UTC |
Andres JuanSee remarks
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $14.22 | $0.00 |
DisclosureSEC source: 0001127602-22-012843 · form4.xml · derivative · entry 3 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,629 Underlying: Common Stock · 2,000 shares Expires 2028-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2021. F2 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| April 29, 2022 Filed May 2, 2022 20:24 UTC |
Andres JuanSee remarks
|
SaleCommon Stock | 2,000 | $150.00 | $300,000.00 |
DisclosureSEC source: 0001127602-22-012843 · form4.xml · nonDerivative · entry 2 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,069 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2021. Read SEC document |
| April 29, 2022 Filed May 2, 2022 20:24 UTC |
Andres JuanSee remarks
|
Exercise / conversionCommon Stock | 2,000 | $14.22 | $28,440.00 |
DisclosureSEC source: 0001127602-22-012843 · form4.xml · nonDerivative · entry 1 Andres Juan · CIK 0001760670 · See remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,069 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2021. Read SEC document |
| April 28, 2022 Filed Apr 29, 2022 20:18 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 10,000 | $143.73 | $1,437,300.00 |
DisclosureSEC source: 0001127602-22-012747 · form4.xml · nonDerivative · entry 8 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 6,914,880 F9 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 18, 2018, as amended on September 16, 2019. F10 · ownership.nature: These shares are owned directly by OCHA LLC ("OCHA"). The reporting person is the majority equity unit holder and the sole managing member of OCHA. The reporting person disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 or any other purpose. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:42 UTC |
SAGAN PAULDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,415 | $0.00 Strike: $142.52 | $0.00 |
DisclosureSEC source: 0001127602-22-012858 · form4.xml · derivative · entry 6 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,415 Underlying: Common Stock · 5,415 shares Expires not disclosed F4 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. F4 · derivative.expiration_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:42 UTC |
SAGAN PAULDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 703 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012858 · form4.xml · derivative · entry 5 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 703 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. F3 · derivative.expiration_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:42 UTC |
SAGAN PAULDirector
|
Exercise / conversionCommon Stock | 703 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012858 · form4.xml · nonDerivative · entry 1 SAGAN PAUL · CIK 0001035440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:47 UTC |
Berenson StephenDirector
|
GrantRestricted Stock Units · Derivative | 670 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012859 · form4.xml · derivative · entry 4 Berenson Stephen · CIK 0001760671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 670 Underlying: Common Stock · 670 shares Expires not disclosed F4 · derivative.exercise_date: The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. F4 · derivative.expiration_date: The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:47 UTC |
Berenson StephenDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,061 | $0.00 Strike: $142.52 | $0.00 |
DisclosureSEC source: 0001127602-22-012859 · form4.xml · derivative · entry 3 Berenson Stephen · CIK 0001760671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,061 Underlying: Common Stock · 4,061 shares Expires not disclosed F3 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. F3 · derivative.expiration_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:47 UTC |
Berenson StephenDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 703 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012859 · form4.xml · derivative · entry 2 Berenson Stephen · CIK 0001760671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 703 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. F2 · derivative.expiration_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:47 UTC |
Berenson StephenDirector
|
Exercise / conversionCommon Stock | 703 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012859 · form4.xml · nonDerivative · entry 1 Berenson Stephen · CIK 0001760671 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 28, 2022 Filed May 3, 2022 00:24 UTC |
Afeyan NoubarDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 703 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012938 · form4.xml · derivative · entry 7 AFEYAN NOUBAR · CIK 0001222012 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 703 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F7 · derivative.exercise_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. F7 · derivative.expiration_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. Read SEC document |
| April 28, 2022 Filed May 3, 2022 00:24 UTC |
Afeyan NoubarDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,415 | $0.00 Strike: $142.52 | $0.00 |
DisclosureSEC source: 0001127602-22-012938 · form4.xml · derivative · entry 6 AFEYAN NOUBAR · CIK 0001222012 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,415 Underlying: Common Stock · 5,415 shares Expires 2032-04-28 F6 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document |
| April 28, 2022 Filed May 3, 2022 00:24 UTC |
Afeyan NoubarDirector
|
Exercise / conversionCommon Stock | 703 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012938 · form4.xml · nonDerivative · entry 1 AFEYAN NOUBAR · CIK 0001222012 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,239,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:45 UTC |
LANGER ROBERTDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,415 | $0.00 Strike: $142.52 | $0.00 |
DisclosureSEC source: 0001127602-22-012860 · form4.xml · derivative · entry 6 LANGER ROBERT · CIK 0001239757 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,415 Underlying: Common Stock · 5,415 shares Expires not disclosed F3 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. F3 · derivative.expiration_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:45 UTC |
LANGER ROBERTDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 703 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012860 · form4.xml · derivative · entry 5 LANGER ROBERT · CIK 0001239757 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 703 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. F2 · derivative.expiration_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:45 UTC |
LANGER ROBERTDirector
|
Exercise / conversionCommon Stock | 703 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012860 · form4.xml · nonDerivative · entry 1 LANGER ROBERT · CIK 0001239757 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,467,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:40 UTC |
Nader FrancoisDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,415 | $0.00 Strike: $142.52 | $0.00 |
DisclosureSEC source: 0001127602-22-012857 · form4.xml · derivative · entry 3 Nader Francois · CIK 0001365343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,415 Underlying: Common Stock · 5,415 shares Expires not disclosed F3 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. F3 · derivative.expiration_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:40 UTC |
Nader FrancoisDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 703 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012857 · form4.xml · derivative · entry 2 Nader Francois · CIK 0001365343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 703 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. F2 · derivative.expiration_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:40 UTC |
Nader FrancoisDirector
|
Exercise / conversionCommon Stock | 703 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012857 · form4.xml · nonDerivative · entry 1 Nader Francois · CIK 0001365343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:39 UTC |
Tallett Elizabeth EDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,415 | $0.00 Strike: $142.52 | $0.00 |
DisclosureSEC source: 0001127602-22-012856 · form4.xml · derivative · entry 3 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,415 Underlying: Common Stock · 5,415 shares Expires not disclosed F3 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. F3 · derivative.expiration_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:39 UTC |
Tallett Elizabeth EDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 703 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012856 · form4.xml · derivative · entry 2 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 703 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. F2 · derivative.expiration_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:39 UTC |
Tallett Elizabeth EDirector
|
Exercise / conversionCommon Stock | 703 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012856 · form4.xml · nonDerivative · entry 1 Tallett Elizabeth E · CIK 0001192460 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:38 UTC |
Horning SandraDirector
|
GrantRestricted Stock Units · Derivative | 670 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012854 · form4.xml · derivative · entry 4 Horning Sandra · CIK 0001638709 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 670 Underlying: Common Stock · 670 shares Expires not disclosed F4 · derivative.exercise_date: The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. F4 · derivative.expiration_date: The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:38 UTC |
Horning SandraDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,061 | $0.00 Strike: $142.52 | $0.00 |
DisclosureSEC source: 0001127602-22-012854 · form4.xml · derivative · entry 3 Horning Sandra · CIK 0001638709 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,061 Underlying: Common Stock · 4,061 shares Expires not disclosed F3 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. F3 · derivative.expiration_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:38 UTC |
Horning SandraDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 703 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012854 · form4.xml · derivative · entry 2 Horning Sandra · CIK 0001638709 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 703 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. F2 · derivative.expiration_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:38 UTC |
Horning SandraDirector
|
Exercise / conversionCommon Stock | 703 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012854 · form4.xml · nonDerivative · entry 1 Horning Sandra · CIK 0001638709 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:37 UTC |
NABEL ELIZABETH GDirector
|
GrantRestricted Stock Units · Derivative | 670 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012852 · form4.xml · derivative · entry 4 NABEL ELIZABETH G · CIK 0001619929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 670 Underlying: Common Stock · 670 shares Expires not disclosed F4 · derivative.exercise_date: The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. F4 · derivative.expiration_date: The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:37 UTC |
NABEL ELIZABETH GDirector
|
GrantStock Option (Right to Buy) · Derivative | 4,061 | $0.00 Strike: $142.52 | $0.00 |
DisclosureSEC source: 0001127602-22-012852 · form4.xml · derivative · entry 3 NABEL ELIZABETH G · CIK 0001619929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,061 Underlying: Common Stock · 4,061 shares Expires not disclosed F3 · derivative.exercise_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. F3 · derivative.expiration_date: This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:37 UTC |
NABEL ELIZABETH GDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 703 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012852 · form4.xml · derivative · entry 2 NABEL ELIZABETH G · CIK 0001619929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 703 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. F2 · derivative.expiration_date: The shares subject to this restricted stock unit award vested in full on April 28, 2022. Read SEC document |
| April 28, 2022 Filed May 2, 2022 20:37 UTC |
NABEL ELIZABETH GDirector
|
Exercise / conversionCommon Stock | 703 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-012852 · form4.xml · nonDerivative · entry 1 NABEL ELIZABETH G · CIK 0001619929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 20:18 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
GiftCommon Stock | 4,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-012747 · form4.xml · nonDerivative · entry 7 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,417,535 F7 · kind: The reported disposition was effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2020, as amended May 13, 2021. F8 · price: The reported disposition represents a bona fide charitable gift made by the reporting person. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 20:18 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 26 | $145.34 | $3,778.84 |
DisclosureSEC source: 0001127602-22-012747 · form4.xml · nonDerivative · entry 6 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,421,535 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as amended on May 21, 2020. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 20:18 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 699 | $143.87 | $100,565.13 |
DisclosureSEC source: 0001127602-22-012747 · form4.xml · nonDerivative · entry 5 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,421,561 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as amended on May 21, 2020. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.66 to $144.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 20:18 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 2,502 | $143.12 | $358,086.24 |
DisclosureSEC source: 0001127602-22-012747 · form4.xml · nonDerivative · entry 4 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,422,260 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as amended on May 21, 2020. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $142.65 to $143.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 20:18 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 2,500 | $142.22 | $355,550.00 |
DisclosureSEC source: 0001127602-22-012747 · form4.xml · nonDerivative · entry 3 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,424,762 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as amended on May 21, 2020. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $141.64 to $142.64. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 20:18 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 2,724 | $141.10 | $384,356.40 |
DisclosureSEC source: 0001127602-22-012747 · form4.xml · nonDerivative · entry 2 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,427,262 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as amended on May 21, 2020. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.63 to $141.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 27, 2022 Filed Apr 29, 2022 20:18 UTC |
Bancel StephaneDirector · Chief Executive Officer
|
SaleCommon Stock | 549 | $140.19 | $76,964.31 |
DisclosureSEC source: 0001127602-22-012747 · form4.xml · nonDerivative · entry 1 Bancel Stephane · CIK 0001443340 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,429,986 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as amended on May 21, 2020. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $139.60 to $140.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| April 25, 2022 Filed Apr 26, 2022 20:07 UTC |
Hoge StephenPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $0.99 | $0.00 |
DisclosureSEC source: 0001127602-22-012513 · form4.xml · derivative · entry 19 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,431 Underlying: Common Stock · 10,000 shares Expires 2023-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021. F13 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| April 25, 2022 Filed Apr 26, 2022 20:07 UTC |
Hoge StephenPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $10.90 | $0.00 |
DisclosureSEC source: 0001127602-22-012513 · form4.xml · derivative · entry 18 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,972 Underlying: Common Stock · 5,000 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021. F13 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| April 25, 2022 Filed Apr 26, 2022 20:07 UTC |
Hoge StephenPresident
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $10.90 | $0.00 |
DisclosureSEC source: 0001127602-22-012513 · form4.xml · derivative · entry 17 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,972 Underlying: Common Stock · 5,000 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021. F13 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| April 25, 2022 Filed Apr 26, 2022 20:07 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 100 | $150.95 | $15,095.00 |
DisclosureSEC source: 0001127602-22-012513 · form4.xml · nonDerivative · entry 14 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,622,532 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021. Read SEC document |
| April 25, 2022 Filed Apr 26, 2022 20:07 UTC |
Hoge StephenPresident
|
SaleCommon Stock | 1,486 | $150.32 | $223,375.52 |
DisclosureSEC source: 0001127602-22-012513 · form4.xml · nonDerivative · entry 13 Hoge Stephen · CIK 0001760669 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,622,632 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 27, 2018, as amended on January 7, 2021. F11 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $149.94 to $150.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.